Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Honeywell
|
| gptkbp:acquired |
gptkb:Baxter_International
|
| gptkbp:acquisition |
gptkb:2013
|
| gptkbp:audience |
engages with customers regularly
|
| gptkbp:awards |
various industry awards
|
| gptkbp:brand |
strong brand recognition in healthcare
|
| gptkbp:business_model |
gptkb:hospital
|
| gptkbp:certification |
ISO certified
|
| gptkbp:clinical_trial |
conducts clinical trials
|
| gptkbp:community_involvement |
supports healthcare initiatives
|
| gptkbp:customer_base |
hospitals and clinics
|
| gptkbp:customer_support |
provides clinical support services
|
| gptkbp:employees |
approximately 10,000
|
| gptkbp:feedback |
high customer satisfaction ratings
|
| gptkbp:financial_performance |
strong financial performance
|
| gptkbp:focus |
chronic kidney disease
|
| gptkbp:founded |
gptkb:1964
|
| gptkbp:founder |
gptkb:Gösta_G._M._Gambro
|
| gptkbp:future_plans |
expansion of product offerings
|
| gptkbp:global_presence |
operates in over 100 countries
|
| gptkbp:headquarters |
gptkb:Sweden
gptkb:Stockholm,_Sweden |
| gptkbp:historical_event |
established in 1964
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gambro
|
| gptkbp:industry |
gptkb:Insurance_Company
|
| gptkbp:innovation |
focus on technology advancements
dialysis technology |
| gptkbp:key_people |
Thomas D. D. M. H. Gambro
|
| gptkbp:leadership |
leader in dialysis market
|
| gptkbp:location |
gptkb:Europe
|
| gptkbp:market |
healthcare
|
| gptkbp:mission |
improving patient care
|
| gptkbp:operates_in |
over 100 countries
global market |
| gptkbp:parent_company |
gptkb:Baxter_International
gptkb:Baxter_International_Inc. |
| gptkbp:part_of |
Baxter's renal division
|
| gptkbp:partnership |
leading healthcare organizations
|
| gptkbp:partnerships |
various healthcare providers
collaborates for research initiatives |
| gptkbp:population_trend |
adapts to market trends
|
| gptkbp:product_line |
hemodialysis and peritoneal dialysis
|
| gptkbp:products |
continuous product development
dialysis equipment |
| gptkbp:regulatory_compliance |
complies with regulatory standards
|
| gptkbp:research_and_development |
invests in R& D
|
| gptkbp:revenue |
$1.5 billion (2012)
|
| gptkbp:services |
renal care
|
| gptkbp:social_responsibility |
committed to social responsibility initiatives
|
| gptkbp:specialization |
dialysis services
|
| gptkbp:subsidiary |
gptkb:Gambro_Healthcare
|
| gptkbp:supply_chain |
efficient supply chain management
|
| gptkbp:sustainability |
focuses on sustainable practices
|
| gptkbp:tactics |
expansion in emerging markets
|
| gptkbp:technology |
advanced dialysis systems
|
| gptkbp:training |
ongoing employee training programs
offers training programs for healthcare professionals |
| gptkbp:treatment |
improves patient outcomes through innovation
|
| gptkbp:type |
private company
|
| gptkbp:type_of_care |
focuses on patient-centered care
|
| gptkbp:vision |
leading provider of renal care
|
| gptkbp:website |
www.gambro.com
|